Adherence to post-surgery follow-up assessment and its association with sociodemographic and disease characteristics in patients with breast cancer in Central China
- PMID: 33183247
- PMCID: PMC7659108
- DOI: 10.1186/s12885-020-07600-y
Adherence to post-surgery follow-up assessment and its association with sociodemographic and disease characteristics in patients with breast cancer in Central China
Abstract
Background: Follow-up after curative surgery is increasingly recognized as an important component of breast cancer care. Although current guideline regulates the follow-ups, there are no relevant studies on the adherence to it in China. This study investigated the post-surgery follow-up and explored its association with patients, tumor and treatment characteristics.
Methods: A total of 711 patients underwent surgical treatment in Shanxi Bethune Hospital from March 2012 to May 2018 were included in this study. Baseline sociodemographic, tumor, and treatment characteristics were obtained from the hospital electronic medical records. The post-surgery follow-up was reviewed and assessed from the patient's follow-up examination record. Factors associated with the first three-year follow up was evaluated using logistic regression analysis.
Results: The annual follow-up rate after surgery decreased gradually from 67.1% at the 1st year, 60.2% at the 3rd year to 51.9% at the 4th year, and 43.5% at the 5th year. Loss of follow-up during the first 3 years after surgery was significantly associated with older age (> 65 years), lower medical insurance coverage, axillary lymph node dissection, and less intensity of systemic treatment.
Conclusion: A significant downtrend of annual follow-up rate for breast cancer survivors was confirmed in this study. Loss of follow-up within the first 3 years after surgery was associated with both patient's characteristics and treatment. These results will provide evidence to help clinicians to develop tailored patient management after curative surgery.
Keywords: Adherence; Breast cancer; China; Follow-up.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
The Association of Extent of Axillary Surgery and Survival in Women with N2-3 Invasive Breast Cancer.Ann Surg Oncol. 2018 Oct;25(10):3019-3029. doi: 10.1245/s10434-018-6587-2. Epub 2018 Jul 5. Ann Surg Oncol. 2018. PMID: 29978365 Free PMC article.
-
De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study.Breast Cancer Res Treat. 2020 Apr;180(3):725-733. doi: 10.1007/s10549-020-05589-3. Epub 2020 Mar 16. Breast Cancer Res Treat. 2020. PMID: 32180074 Free PMC article.
-
Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.J Surg Oncol. 2004 Oct 1;88(1):4-7; discussion 7-8. doi: 10.1002/jso.20101. J Surg Oncol. 2004. PMID: 15384064
-
[Breast-conserving surgery in breast cancer].G Chir. 2005 Nov-Dec;26(11-12):449-52. G Chir. 2005. PMID: 16472427 Review. Italian.
-
[Current surgical therapy of breast carcinoma and subsequent requirements for histopathologic diagnosis].Zentralbl Chir. 1997;122(2):74-8. Zentralbl Chir. 1997. PMID: 9173761 Review. German.
Cited by
-
A cross-sectional study on knowledge, attitude and practice of osteoporosis prevention in patients with breast cancer undergoing endocrine therapy: A cross-sectional study.Asia Pac J Oncol Nurs. 2025 Feb 26;12:100678. doi: 10.1016/j.apjon.2025.100678. eCollection 2025 Dec. Asia Pac J Oncol Nurs. 2025. PMID: 40271527 Free PMC article.
-
Changes in Pain Sensitivity in Treatment for Breast Cancer: A 12-Month Follow-Up Case Series.Int J Environ Res Public Health. 2022 Mar 29;19(7):4055. doi: 10.3390/ijerph19074055. Int J Environ Res Public Health. 2022. PMID: 35409738 Free PMC article.
References
-
- Zhang ML, Peng P, Wu CX, Gong YM, Zhang SW, Chen WQ, et al. Report of breast cancer incidence and mortality in China registry regions,2008-2012. Zhonghua Zhong Liu Za Zhi. 2019;41:315–320. - PubMed
-
- Clinical Practice Guidelines in Oncology. Breast cancer – V.3: National Comprehensive Cancer Network; 2019. https://www.nccn.org/professionals/development.aspx. Accessed 25 Nov 2019.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical